Dec 14, 2023 / 01:30PM GMT
Operator
Welcome to the Regeneron Pharmaceuticals ASH 2023 Investor Conference Call. My name is Shannon, and I'll be your operator for today's call. (Operator Instructions) Please note that this conference is being recorded.
I will now turn the call over to Ryan Crowe, Vice President, Investor Relations. You may begin.
Ryan Crowe - Regeneron Pharmaceuticals, Inc. - VP of IR
Thank you, Shannon. Good morning, good afternoon, and good evening to everyone listening around the globe. Welcome to Regeneron's ASH 2023 investor call.
I'd like to remind you that remarks made on today's call may include forward-looking statements about Regeneron's business and research and development programs, anticipated milestones, and regulatory matters. Each forward-looking statement is subject to risks and uncertainties that could cause the actual results and events to differ materially from those projected in that statement. A more complete description of these and other material risks can be found in Regeneron's SEC filings. Regeneron does not undertake any obligation to
Regeneron Pharmaceuticals Inc to Host Investor Call Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers